Rebecca S Cook Selected Research

Rebecca S Cook Research Topics

Disease

53	Neoplasms (Cancer) 02/2024 - 12/2009
34	Breast Neoplasms (Breast Cancer) 01/2023 - 12/2009
12	Triple Negative Breast Neoplasms 02/2024 - 01/2012
9	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2013
2	Inflammation (Inflammations) 06/2023 - 01/2015
2	Residual Neoplasm 01/2019 - 07/2012
2	Melanoma (Melanoma, Malignant) 01/2018 - 08/2013
1	Arthritis (Polyarthritis) 06/2023
1	Rheumatoid Arthritis 06/2023
1	Osteoarthritis 06/2023
1	Necrosis 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Virus Diseases (Viral Diseases) 06/2018
1	Disease Progression 01/2018
1	Infections 01/2018
1	Cystitis 01/2018
1	Urolithiasis 01/2018
1	Circulating Neoplastic Cells 01/2018
1	Carcinogenesis 02/2015

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2011
8	CytokinesIBA 01/2020 - 08/2013
8	Lapatinib (GW572016)FDA Link 01/2019 - 03/2011
7	Small Interfering RNA (siRNA)IBA 02/2024 - 03/2011
6	Phosphotransferases (Kinase)IBA 01/2018 - 06/2011
6	Trastuzumab (Herceptin)FDA Link 02/2015 - 12/2009
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 10/2013
5	Estrogen ReceptorsIBA 09/2019 - 01/2012
5	Phenobarbital (Luminal)FDA Link 01/2018 - 08/2013
4	c-Mer Tyrosine KinaseIBA 01/2019 - 12/2010
4	Mechanistic Target of Rapamycin Complex 2IBA 01/2019 - 01/2016
3	AlbuminsIBA 02/2024 - 02/2023
3	EnzymesIBA 11/2021 - 01/2018
3	Mechanistic Target of Rapamycin Complex 1IBA 01/2019 - 01/2016
3	RNA (Ribonucleic Acid)IBA 01/2018 - 03/2013
3	human ERBB2 proteinIBA 06/2017 - 01/2012
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015 - 05/2014
2	Serum AlbuminIBA 02/2024 - 02/2023
2	LipidsIBA 02/2024 - 02/2023
2	protein phosphatase 4IBA 01/2022 - 07/2012
2	ChemokinesIBA 01/2020 - 11/2018
2	navitoclaxIBA 09/2019 - 01/2018
2	Immune Checkpoint InhibitorsIBA 02/2019 - 03/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 03/2013
2	Fulvestrant (Faslodex)FDA Link 01/2018 - 10/2013
2	LigandsIBA 01/2018 - 10/2013
2	Estrogens (Estrogen)FDA Link 01/2018 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 11/2012
2	ErbB Receptors (EGF Receptor)IBA 07/2015 - 06/2011
2	Interleukin-10 (Interleukin 10)IBA 11/2014 - 08/2013
2	ClaudinsIBA 10/2013 - 08/2013
2	Tyrosine Kinase InhibitorsIBA 05/2012 - 06/2011
1	Matrix Metalloproteinases (MMPs)IBA 06/2023
1	PolymersIBA 01/2023
1	MethacrylatesIBA 01/2023
1	butyl methacrylateIBA 01/2023
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	GlutaminaseIBA 01/2021
1	Delta CateninIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	cadherin 5IBA 12/2020
1	Thromboxane Receptors (Thromboxane Receptor)IBA 12/2020
1	LuciferasesIBA 10/2019
1	Nucleic AcidsIBA 10/2019
1	VU661013IBA 09/2019
1	Everolimus FDA Link 09/2019
1	XL147IBA 01/2019
1	AntigensIBA 01/2019
1	Coenzymes (Enzyme Cofactors)IBA 01/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019
1	Proteasome InhibitorsIBA 01/2019
1	Therapeutic UsesIBA 11/2018
1	NucleotidesIBA 11/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 06/2018
1	Aromatase InhibitorsIBA 01/2018
1	StruviteIBA 01/2018
1	Programmed Cell Death 1 ReceptorIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Interferon-gamma (Interferon, gamma)IBA 01/2018
1	A-factor (Streptomyces)IBA 06/2017
1	rho Guanine Nucleotide Dissociation Inhibitor betaIBA 06/2017
1	CaspasesIBA 01/2017
1	Janus Kinase 2IBA 04/2016
1	locked nucleic acidIBA 12/2015
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 12/2015
1	Antisense OligonucleotidesIBA 12/2015
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2015
1	Epidermal Growth Factor (EGF)IBA 12/2015
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2015
1	CollagenIBA 02/2015
1	Interleukin-13IBA 11/2014
1	Interleukin-4 (Interleukin 4)IBA 11/2014
1	Antineoplastic Agents (Antineoplastics)IBA 09/2014

Therapy/Procedure

12	Therapeutics 02/2024 - 01/2012
7	Drug Therapy (Chemotherapy) 01/2018 - 07/2012
5	Immunotherapy 01/2019 - 03/2016
4	Neoadjuvant Therapy 01/2018 - 07/2012
1	Intravenous Injections 01/2023
1	Radiotherapy 02/2015